Difficulty: Medium
Average Score: 77%
Practice
A 57-year-old woman presents to the emergency department with crushing chest pain. She reports having a similar episode 2 weeks ago while shoveling snow, but the pain was much less and it went away as soon as she stopped shoveling. An ECG reveals ST segment elevation, and the doctor administers a fibrinolytic drug. Her symptoms resolve, but later she begins to vomit up blood. Which would be an appropriate medication to give now?
Correct answer
B
Rationale
The correct answer is B) Aminocaproic acid. Aminocaproic acid is a medication used to treat bleeding disorders by preventing the breakdown of blood clots. In this case, the patient is experiencing vomiting blood, which indicates a potential bleeding issue likely due to the fibrinolytic drug administration. Aminocaproic acid can help stop the bleeding by stabilizing blood clots.
Option A) Abciximab is a glycoprotein IIb/IIIa receptor antagonist used as an antiplatelet agent, not indicated for treating bleeding disorders like in this scenario.
Option C) Anistreplase is a thrombolytic agent used to dissolve blood clots and is not appropriate for managing bleeding complications.
Option D) Clopidogrel is an antiplatelet medication that inhibits platelet aggregation and is not the best choice for managing active bleeding.
Educationally, understanding the mechanism of action of drugs is crucial in clinical decision-making. In this case, knowledge of aminocaproic acid's role in stabilizing blood clots can help healthcare providers appropriately manage bleeding complications in patients receiving fibrinolytic therapy. It highlights the importance of considering drug mechanisms and indications in clinical practice to ensure patient safety and optimal outcomes.
Option A) Abciximab is a glycoprotein IIb/IIIa receptor antagonist used as an antiplatelet agent, not indicated for treating bleeding disorders like in this scenario.
Option C) Anistreplase is a thrombolytic agent used to dissolve blood clots and is not appropriate for managing bleeding complications.
Option D) Clopidogrel is an antiplatelet medication that inhibits platelet aggregation and is not the best choice for managing active bleeding.
Educationally, understanding the mechanism of action of drugs is crucial in clinical decision-making. In this case, knowledge of aminocaproic acid's role in stabilizing blood clots can help healthcare providers appropriately manage bleeding complications in patients receiving fibrinolytic therapy. It highlights the importance of considering drug mechanisms and indications in clinical practice to ensure patient safety and optimal outcomes.